DawnLaurynHershmanMD

PubMed

• 74 citations
  The National Cancer Institute Clinical Trials Planning Meeting for Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy.
  Susan G. Dorsey, Ian R. Kleckner, Debra L. Barton, Karen M. Mustian, Ann M. O'Mara
  Journal of the National Cancer Institute. 2019-06-01
• 765 citations
  Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
  Dawn L. Hershman, Christina Lacchetti, Robert H. Dworkin, Ellen M. Lavoie Smith, Jonathan Bleeker
  Journal of Clinical Oncology. 2014-06-20
• 422 citations
  Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update
  Charles L. Loprinzi, Christina Lacchetti, Jonathan Bleeker, Guido Cavaletti, Cynthia Chauhan
  Journal of Clinical Oncology. 2020-07-14

Journal Articles

• Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women with Early-Stage Breast CancerA Randomized Clin...  
  Dawn L Hershman, Jillian L Capodice, William H Kreisle, Michael J Fisch, Marianne K Melnik, Alice T Kengla, Carla W Jorgensen, Heather Greenlee, JAMA
• Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology Statement  
  Ligibel JA, Alfano CM, Hershman DL, Ballard RM, Bruinooge SS, Courneya KS, Daniels EC, Demark-Wahnefried W, Frank ES, Goodwin PJ, Irwin ML, Levit LA, McCaskill-Stevens..., J Clin Oncol, 1/31/2015
• Population-based assessment of determining predictors for quality of prostate cancer surveillance  
  Chamie K, Williams SB, Hershman DL, Wright JD, Nguyen PL, Hu JC, Cancer, 1/26/2015
• Relationship Between Surgical Oncologic Outcomes and Publically Reported Hospital Quality and Satisfaction Measures  
  Wright, JD, Tergas, AI, Ananth, CV, Burke, WM, Chen, L, Neugut, AI, Richards, CA, Hershman, DL, Journal of the National Cancer Institute, 1/24/2015
• Population-level trends in relative survival for cervical cancer  
  Wright JD, Chen L, Tergas AI, Burke WM, Hou JY, Neugut AI, Ananth CV, Hershman DL, Am J Obstet Gynecol, 1/23/2015
• Measurement and validation of frailty as a predictor of outcomes in women undergoing major gynaecological surgery  
  George EM, Burke WM, Hou JY, Tergas AI, Chen L, Neugut AI, Ananth CV, Hershman DL, Wright JD, BJOG, 1/23/2015
• Complications following stereotactic needle biopsy of intracranial tumors  
  Malone H, Yang J, Hershman DL, Wright JD, Bruce JN, Neugut AI, World Neurosurg, 1/22/2015
• Household net worth, racial disparities and hormonal therapy adherence among women with early stage breast cancer  
  Hershman DL, Tsui J, Wright DW, Coromilis, E, Neugut AI, J. Clin. Oncol, 1/20/2015
• Trends in Use and Safety of Image-Guided Transthoracic Needle Biopsies in Cancer Patients  
  Accordino M, Wright JD, Buono D, Neugut AI, Hershman DL, J Oncol Pract, 1/20/2015
• Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer  
  Dinkelspiel HE, Tergas AI, Zimmerman LA, Burke WM, Hou JY, Chen L, Hillyer G, Neugut AI, Hershman DL, Wright JD, Gynecol Oncol, 1/20/2015
• Utilization and Prevalence of Underlying Pathology in Women Who Undergo Electric Power Morcellation for Myomectomy  
  Wright, JD, Tergas, AI, Ananth, CV, Burke, WM, Chen, L, Neugut, AI, Hershman, DL, JAMA Oncology, 1/19/2015
• Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ  
  Reimers LL, Sivasubramanian PS, Hershman DL, Terry MB, Greenlee H, Campbell J, Kalinsky K, Maurer M, Jayasena R, Sandoval R, Alvarez M, Crew KD, Breast J, 1/16/2015
• Serum Tumor Marker Use in Patients With Advanced Solid Tumors  
  Accordino MK, Wright JD, Vasan S, Neugut AI, Tergas A, Hu JC, Hershman DL, J Oncol Pract, 1/15/2015
• Patient Income Level and Cancer Clinical Trial Participation: A Prospective Survey Study  
  Unger JM, Gralow JR, Albain KS, Ramsey SD, Hershman DL, JAMA Oncol, 1/15/2015
• Quality and Outcomes of Treatment of Hypercalcemia of Malignancy  
  Wright JD, Tergas AI, Ananth CV, Burke WM, Hou JY, Chen L, Neugut AI, Richards CA, Hershman DL, Cancer Invest, 1/14/2015
• Influence of Treatment Center and Hospital Volume on Survival for Locally Advanced Cervical Cancer  
  Wright JD, Huang Y, Ananth CV, Tergas AI, Duffy C, Deutsch I, Burke WM, Hou JY, Neugut AI, Hershman DL, Gynecol Oncol, 1/12/2015
• Randomized Multicenter Placebo- Controlled Trial of Omega-3-Fatty Acids for the control of Aromatase Inhibitor-Induced Musculoskeletal Pain (S0927)  
  Hershman DL, Unger JM, Crew KD, Awad D, Dakhil S, Gralow J, Greenlee H, Lew DL, Minasian L, Till C, Wade JL, Meyskens F, Moinpour C, J Clin Oncol, 1/10/2015
• Economic and Survival Implications of Use of Electric Power Morcellation for Hysterectomy for Presumed Benign Gynecologic Disease  
  Wright JD, Cui RR, Wang A, Chen L, Tergas AI, Burke WM, Ananth CV, Hou JY, Neugut AI, Temkin SM, Wang YC, Hershman DL, . Natl Cancer Inst, 1/8/2015
• Factors Associated With 30-Day Hospital Readmission After Hysterectomy  
  Dessources K, Hou JY, Tergas AI, Burke WM, Ananth CV, Prendergast E, Chen L, Neugut AI, Hershman DL, Wright JD, Obstet Gynecol, 1/7/2015
• High versus low-dose rate brachytherapy for cervical cancer  
  Patankar SS, Tergas AI, Deutsch I, Burke WM, Hou JY, Ananth CV, Huang Y, Neugut AI, Hershman DL, Wright JD, Gynecol Oncol, 1/6/2015
• Cocinar Para Su Salud: Randomized Controlled Trial of a Culturally Based Dietary Intervention among Hispanic Breast Cancer Survivors  
  Greenlee H, Gaffney AO, Aycinena AC, Koch P, Contento I, Karmally W, Richardson JM, Lim E, Tsai WY, Crew K, Maurer M, Kalinsky K, Hershman DL, J Acad Nutr Diet, 1/5/2015
• Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA32  
  Goodwin PJ, Parulekar WR, Gelmon KA, Shepherd LE, Ligibel JA, Hershman DL, Rastogi P, Mayer IA, Hobday TJ, Lemieux J, Thompson AM, Pritchard KI, Whelan TJ, Mukherjee S..., J Natl Cancer Inst, 1/4/2015
• Racial/Ethnic and Socioeconomic Differences in Short-Term Breast Cancer Survival Among Women in an Integrated Health System  
  Keegan TH, Kurian AW, Gali K, Tao L, Lichtensztajn DY, Hershman DL, Habel LA, Caan BJ, Gomez SL, Am J Public Health, 1/1/2015
• Dietary modifications, weight loss, and changes in metabolic markers affect global DNA methylation in Hispanic, african american, and afro- Caribbean breast cancer sur...  
  Delgado-Cruzata L, Zhang W, McDonald JA, Tsai WY, Valdovinos C, Falci L, Wang Q, Crew KD, Santella RM, Hershman DL, Greenlee H, J Nutr, 1/1/2015
• Food environments are relevant to recruitment and adherence in dietary modification trials  
  Feathers A, Aycinena AC, Lovasi GS, Rundle A, Gaffney AO, Richardson J, Hershman DL, Koch P, Contento I, Greenlee H, Nutr Res, 1/1/2015
• Join now to see all

Books/Book Chapters

• Gender differences in Medicine 
  Chapter: Cancer Survivorship: Breast and Prostate Cancer 
  Hershman, D. Ritchie, E. Rosner, Z2004
• Diseases of the Breast 
  Chapter: Managing Menopausal Symptoms in Breast Cancer Patients 
  Hershman, D. Loprinzi, CEdition 3rd,2004
• The Paget Foundation for Bone Disorders 
  Chapter: Questions and Answers about Breast Cancer Metastatic to Bone 
  Hershman, D.2001
• Cardiovascular Drug Therapy 
  Chapter: Ultrashort-acting beta-adrenoceptor blocking drug: Esmolol 
  Frishman, W.; Murthy, V., Strom, J.; Hershman, DEditors: Messerli, F.Philadelphia, PAEdition 2nd,1994
• Cardiovascular Drug Therapy 
  Chapter: Amlodipine 
  Frishman, W.; Hershman, D.Editors: Messerli, F.Philadelphia, PAEdition 2nd,1994
• Join now to see all

Lectures

• Association of baseline cardiovascular risk factors and health care utilization and costs in elderly breast cancer patients enrolled in SWOG clinical trials. 
  2019 ASCO Annual Meeting - 6/1/2019
• Randomized trial of text messaging (TM) to reduce early discontinuation of aromatase inhibitor (AI) therapy in women with breast cancer: SWOG S1105. 
  2019 ASCO Annual Meeting - 6/1/2019
• Long Term Consequences of Intermittent and Continuous Androgen Deprivation in Patients with Metastatic Prostate Cancer 
  1/1/2015
• Relationship between surgical oncologic outcomes and publically reported hospital quality measures 
  1/1/2014
• Off-label and compendia use of chemotherapy in patients with metastatic cancer 
  1/1/2013
• Breast Cancer in Era of Personalized Medicine 
  1/1/2013
• Adherence to oral cancer therapy 
  1/1/2013
• The change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early stage breast cancer 
  1/1/2013
• Prevention of chemotherapy induced peripheral neuropathy 
  NY - 1/1/2012
• Cardiovascular Complications of Anticancer Drugs 
  Chicago, IL - 1/1/2012
• Use of high-intensity surveillance in patients following a diagnosis of stage I-II non-small cell lung cancer 
  1/1/2011
• Improving Aromatase Inhibitor Adherence 
  1/1/2011
• Influence of hospital factors, physician factors and type of health insurance on receipt of immediate post mastectomy reconstruction in young women with breast cancer 
  1/1/2010
• Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early stage breast cancer 
  1/1/2009
• Physical, Psychological and Cognitive Challenges of Long Term Surviviors 
  1/1/2009
• “From Molecular Tumor Markers to Health Behaviors – Promises and Challenges of Cancer Survivorship” Special Session 
  1/1/2009
• Neuropathy Trials Overview 
  1/1/2009
• Predicting and Treating Taxane Neuropathy 
  OH - 1/1/2009
• Early Stage Breast Cancer: Advances in Prognostic and Predictive Tools to Aid Decision Making 
  NY - 1/1/2008
• Breast Cancer: Quality of Care, Survivorship and Late Effects 
  1/1/2008
• Late Effects of Cancer Therapy 
  NY - 1/1/2008
• Breast Cancer Survivorship: Understanding Acute and Long Term Effects of Treatment 
  CT - 1/1/2006
• Disparities in Quality of Cancer Care 
  1/1/2006
• Racial/Ethnic disparities in cancer treatment 
  Charlston, SC - 1/1/2006
• Disparities in cancer outcomes 
  1/1/2005
• Join now to see all